| Kathryn W Byrd, MD | |
|
6401 Poplar Ave, Suite 324, Memphis, TN 38119-4823 | |
| (901) 681-9600 | |
| (901) 681-9608 |
| Full Name | Kathryn W Byrd |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Location | 6401 Poplar Ave, Memphis, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013084953 | NPI | - | NPPES |
| 3075062 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 20339 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kathryn W Byrd, MD 6401 Poplar Ave, Suite 324, Memphis, TN 38119-4823 Ph: (901) 681-9600 | Kathryn W Byrd, MD 6401 Poplar Ave, Suite 324, Memphis, TN 38119-4823 Ph: (901) 681-9600 |
News Archive
Novartis announced today new late-breaking data demonstrating that CosentyxTM provides high levels of skin clearance and sustained efficacy in patients with moderate-to-severe plaque psoriasis while maintaining a favorable safety profile across three years.
Hydrogen peroxide isn't just that bottled colorless liquid in the back of the medicine cabinet that's used occasionally for cleaning scraped knees and cut fingers. It's also a natural chemical in the body that rallies at wound sites, jump-starting immune cells into a series of events. A burst of hydrogen peroxide causes neutrophils, the immune system's first responders, to rush to the wound to fight microorganisms, remove damaged tissue and then start the inflammation process.
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for both large-market as well as orphan indications, today announced that it has entered into an exclusive license agreement with affiliates of Fagron NV for the commercialization of OMS103, Omeros' product for arthroscopic surgery.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the results from its Phase I clinical trial with ALN-VSP, a systemically delivered RNAi therapeutic for the treatment of advanced solid tumors with liver involvement.
› Verified 4 days ago
Dr. Clifford William Sims, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1407 Union Ave Ste 901, Memphis, TN 38104 Phone: 901-526-8393 Fax: 901-526-8331 | |
Priscilla April Lao, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 930 Madison Ave Ste 200, Memphis, TN 38103 Phone: 901-448-6650 Fax: 901-302-2486 | |
Dr. Daniel H Wissinger, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1203 Ridgeway Rd, Ste 201, Memphis, TN 38119 Phone: 901-761-5544 Fax: 901-761-9088 | |
Penny Asbell, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 930 Madison Ave Ste 200, Memphis, TN 38163 Phone: 901-448-6650 | |
Michele A Battles, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 6401 Poplar Ave, Suite 340, Memphis, TN 38119 Phone: 901-683-5500 Fax: 901-683-2900 | |
Dr. Natalie C Kerr, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 930 Madison Ave Ste 400, Memphis, TN 38103 Phone: 901-287-7337 Fax: 901-448-1813 |